Valuation
- Market cap
- —
- Revenue TTM
- $0
- Net income TTM
- $0
- P/E (trailing)
- —
- P/E (forward)
- —
- Profit margin
- 0.00%
- Debt to equity
- —
Trading
- Volume
- 58,900
- Avg volume
- 83,338
- Day's range
- $0.27 – $0.60
- Shares out
- —
- Stochastic %K
- 4%
- Beta
- —
- Analysts
- —
- Price target
- —
Company profile
Quantumzyme Corp., a biotransformation company, focuses on advancing enzyme-based solutions for pharmaceutical manufacturing. It utilizes customer centric research to enhance enzyme activity, by applying quantum mechanics, molecular modelling, AI-driven simulations, and computational enzyme engineering to develop biocatalysts designed to enhance efficiency, reduce waste, and support production. The company was former...
Show more
Quantumzyme Corp., a biotransformation company, focuses on advancing enzyme-based solutions for pharmaceutical manufacturing. It utilizes customer centric research to enhance enzyme activity, by applying quantum mechanics, molecular modelling, AI-driven simulations, and computational enzyme engineering to develop biocatalysts designed to enhance efficiency, reduce waste, and support production. The company was formerly known as Reliant Services, Inc. and changed its name to Quantumzyme Corp. in March 2023. Quantumzyme Corp. was incorporated in 2015 and is based in San Diego, California.
- Industry
- Specialty Chemicals
- Sector
- Basic Materials
- Phone
- 858-203-0312
- Website
- https://www.quantumzymecorp.com
- Address
- 15656 Bernardo Center Drive, Suite 801, San Diego, United States
Latest news
No headlines yet.
